Analysis of the structure and function relationship of human apolipoprotein E in vivo, using adenovirus‐mediated gene transfer
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
We have used adenovirus‐mediated gene transfer in apolipoprotein E (apoE)‐deficient mice (E −/− ) to dissect the domains of apoE required for cholesterol and triglyceride homeostasis in vivo. A dose of 2 × 10 9 pfu of apoE2‐ apoE3‐, or apoE4‐expressing adenoviruses failed to decrease the cholesterol levels of E −/− mice and caused severe hypertriglyceridemia, characterized by accumulation of apoE‐rich and triglyceride‐rich very low density lipoprotein (VLDL). In contrast, the truncated forms apoE4–229 and apoE4–259 at doses of 2 × 10 9 pfu, or 4 × 10 9 pfu, resulted in a 90% reduction in the cholesterol levels of E −/− mice, without affecting plasma triglyceride levels. The triglyceride secretion of mice infected with apoE4 was increased 2.7‐fold compared with that of mice infected with apoE4–259. The apoE truncations did not influence apoE secretion by cells and association with VLDL. The levels of apoE4 and apoE4–229 and apoE4–259 mRNA in the livers of infected animals were similar. The findings suggest that the amino‐terminal 1–229 region of apoE4 contains the domains required for the association of apoE with lipoproteins and their subsequent clearance via apoE‐recognizing receptors. Furthermore, the carboxy‐terminal 260–299 residues of apoE contribute to the apoE‐induced hypertriglyceridemia. Thus, truncated forms of apoE may find useful future application in gene therapy for correction of high cholesterol profiles without triggering hypertriglyceridemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944 · cited 1×
“Female apoE-deficient mice 4-6 wk old were used (44).”
MethodThree-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., & Agard, D. A. (1991) · Science · doi:10.1126/science.2063194 · Cited by 678
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
Reddick, R. L., Zhang, S. H., & Maeda, N. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.141 · Cited by 633
Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation
Linton, M. F., Atkinson, J. B., & Fazio, S. (1995) · Science · doi:10.1126/science.7863332 · Cited by 478 · cited 1×
“The involvement of apoE in cholesterol efflux may explain why, when expressed locally in macrophages or endothelial cells, apoE protects from atherosclerosis (31-33).”
BackgroundInnerarity, T. L., & Mahley, R. W. (1978) · Biochemistry · doi:10.1021/bi00601a013 · Cited by 433
Human Apolipoprotein E Receptor 2
Kim, D.-H., Iijima, H., Goto, K., Sakai, J., Ishii, H., Kim, H.-J., Suzuki, H., Kondo, H., Saeki, S., & Yamamoto, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.8373 · Cited by 384
Rall, S. C., Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.15.4696 · Cited by 345
Dong, L. M., Wilson, C., Wardell, M. R., Simmons, T., Mahley, R. W., Weisgraber, K. H., & Agard, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31797-0 · Cited by 320
Familial apolipoprotein E deficiency.
Schaefer, E. J., Gregg, R. E., Ghiselli, G., Forte, T. M., Ordovas, J. M., Zech, L. A., & Brewer, H. B. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112704 · Cited by 313
Ji, Z. S., Brecht, W. J., Miranda, R. D., Hussain, M. M., Innerarity, T. L., & Mahley, R. W. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82186-x · Cited by 305 · cited 1×
“Heparan sulfate proteoglycans may also be involved in this process (52-55).”
BackgroundIncreased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
Fazio, S., Babaev, V. R., Murray, A. B., Hasty, A. H., Carter, K. J., Gleaves, L. A., Atkinson, J. B., & Linton, M. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4647 · Cited by 295
The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments.
Innerarity, T. L., Friedlander, E. J., Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44180-9 · Cited by 276 · cited 3×
“It was found that mutation in apoE within the vicinity of amino acids 130-160 affected the recognition of this protein by the LDL receptor and resulted in dominant or recessive forms of type III hyperlipoproteinemia (613, 47-49).”
BackgroundType III Hyperlipoproteinemia Associated with Apolipoprotein E Deficiency
Ghiselli, G., Schaefer, E. J., Gascon, P., & Breser, H. B. (1981) · Science · doi:10.1126/science.6795720 · Cited by 274
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding.
Weisgraber, K. H., Innerarity, T. L., Harder, K. J., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44181-0 · Cited by 220
Lalazar, A., Weisgraber, K. H., Rall, S. C., Giladi, H., Innerarity, T. L., Levanon, A. Z., Boyles, J. K., Amit, B., Gorecki, M., & Mahley, R. W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68957-4 · Cited by 209
Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia
Huang, Y., Liu, X. Q., Rall, S. C., Taylor, J. M., von Eckardstein, A., Assmann, G., & Mahley, R. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26388 · Cited by 204
Westerlund, J. A., & Weisgraber, K. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82318-3 · Cited by 164
Wardell, M. R., Brennan, S. O., Janus, E. D., Fraser, R., & Carrell, R. W. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113096 · Cited by 159 · cited 1×
“Mutations in apoE that prevent its binding to the low-density lipoprotein (LDL) receptor and possibly other receptors are associated with type III hyperlipoproteinemia and premature atherosclerosis (6-14).”
BackgroundRensen, P. C. N., & van Berkel, T. J. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.14791 · Cited by 144 · cited 3×
“Consistent with previous findings in humans and in animal models, the current study showed that overexpression of the full-length apoE causes hypertriglyceridemia (25, 26, 34-39) .”
BackgroundResultAleshkov, S., Abraham, C. R., & Zannis, V. I. (1997) · Biochemistry · doi:10.1021/bi9626362 · Cited by 138
Self-citationJi, Z. S., Fazio, S., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36849-7 · Cited by 138
Rall, S. C., Newhouse, Y. M., Clarke, H. R., Weisgraber, K. H., McCarthy, B. J., Mahley, R. W., & Bersot, T. P. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113988 · Cited by 103
Cladaras, C., Hadzopoulou-Cladaras, M., Felber, B. K., Pavlakis, G., & Zannis, V. I. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61655-2 · Cited by 92 · cited 1×
“The role of apoE in cholesterol homeostasis was established unequivocally by studies of human patients and animal models with apoE deficiency or carrying defective apoE forms (15-24).”
BackgroundSelf-citationLipoprotein and receptor interactions in vivo
Herz, J., & Willnow, T. E. (1995) · Current Opinion in Lipidology · doi:10.1097/00041433-199504000-00007 · Cited by 88
Wardell, M. R., Weisgraber, K. H., Havekes, L. M., & Rall, S. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30067-5 · Cited by 80 · cited 1×
“Mutations in apoE that prevent its binding to the low-density lipoprotein (LDL) receptor and possibly other receptors are associated with type III hyperlipoproteinemia and premature atherosclerosis (6-14).”
BackgroundSelf-citationMann, W. A., Gregg, R. E., Sprecher, D. L., & Brewer, H. B. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90043-x · Cited by 75
Smit, M., de Knijff, P., van der Kooij-Meijs, E., Groenendijk, C., van den Maagdenberg, A., Gevers Leuven, J., Stalenhoef, A., Stuyt, P., Frants, R., & Havekes, L. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42759-2 · Cited by 74
Self-citationType III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E
Fazio, S., Lee, Y. L., Ji, Z. S., & Rall, S. C. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116728 · Cited by 71
Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4
van den Maagdenberg, A. M. J. M., de Knijff, P., Stalenhoef, A. F. H., Gevers Leuven, J. A., Havekes, L. M., & Frants, R. R. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(89)80044-0 · Cited by 57
Self-citationJONG, C. M., DAHLMANS, E. H. V., HOFKER, H. M., & HAVEKES, M. L. (1997) · Biochemical Journal · doi:10.1042/bj3280745 · Cited by 55
Cited by
Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes
Tchkonia, T., Giorgadze, N., Pirtskhalava, T., Tchoukalova, Y., Karagiannides, I., Forse, R. A., DePonte, M., Stevenson, M., Guo, W., Han, J., et al. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00653.2001 · Cited by 254
Probing the pathways of chylomicron and HDL metabolism using adenovirus-mediated gene transfer
Zannis, V. I., Chroni, A., Kypreos, K. E., Kan, H.-Y., Cesar, T. B., Zanni, E. E., & Kardassis, D. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200404000-00008 · Cited by 74
Self-citationKypreos, K. E., & Zannis, V. I. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500322-jlr200 · Cited by 45
Self-citationDrosatos, K., Sanoudou, D., Kypreos, K. E., Kardassis, D., & Zannis, V. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700986200 · Cited by 26
Self-citationGeorgiadou, D., Chroni, A., Vezeridis, A., Zannis, V. I., & Stratikos, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027037 · Cited by 24
“Recombinant adenoviruses were constructed as previously described [50] using the Ad-Easy-1 system [51].”
MethodSelf-citation
Metadata
- Authors
- Kypreos, K. E., Teusink, B., van Dijk, K. O. W., Havekes, L. M., & Zannis, V. I.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-05-18
- Volume
- 15
- Issue
- 9
- Pages
- 1598-1600
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2111651979
- Cited by
- 29
- References
- 31
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.